Pages tagged with: cancer
-
Hematopoiesis and immune cell cancer
Plymouth University research: Hematopoiesis and immune cell cancer. Research into the signalling mechanisms involved in hematopoiesis and the pathogenesis of leukaemia and lymphoma
-
Specialist cancer care (degree level)
Plymouth University offers this 'Specialist cancer care' module in partnership with Plymouth Hospitals NHS Trust to enable you to become competent in all aspects regarding the specialist treatment and care of those with cancer.
-
Enhanced care of the patient requiring systemic anti-cancer therapy (SACT) (diploma and degree level)
Plymouth University's 'Enhanced care of the patient requiring chemotherapy' module will enable you to gain a comprehensive understanding of the range and complexity of influencing factors in the delivery of care to patients requiring chemotherapy.
-
Membrane fluidity influences sensitivity of ovarian cancer cell lines to auranofin
Plymouth University news: Increased fluidity in cell membranes could have a major impact on an ovarian cancer cell’s sensitivity to treatment using the anti-rheumatic drug auranofin, research led by Plymouth University suggests
-
Genetic Toxicology and Ecotoxicology Research Group
Plymouth University's Genetic Toxicology & Ecotoxicology Research Group: We work across a wide range of themes including cancer biology, radioecology, molecular and in vitro toxicology, ecotoxicology and aquatic biology
-
Cancer
Plymouth University research: cancer research in the Biomedical Research Group in Plymouth University Peninsula Schools of Medicine and Dentistry
-
Only 20 per cent of men over 50 would opt for surgical treatment if faced with localised prostate cancer
Plymouth University news: A study by psychology academics shows that only 20 per cent of men would opt to have their prostate gland removed if faced with localised prostate cancer.
-
Be Clear on Cancer
This campaign is for both men and women over 50+ and highlights the importance for the need to check for blood in their pee.
-
BRCA1 deficiency increases sensitivity of ovarian cancer cells to auranofin
Plymouth University news: An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study led by Plymouth University has found
-
![DNA molecule (credit: By Christoph Bock (Max Planck Institute for Informatics) (Own work) [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons)](https://d39ner1f41xyl1.cloudfront.net/uploads/production/media_asset/file/6/6619/small_DNA_methylation__cropped_.jpg)
Conference explores impact of environmental agents on DNA
Plymouth University news: The 38th Annual Conference of UKEMS (the UK branch of the European Environmental Mutagen Society) is being staged at Plymouth University
-
Cancer Research UK-backed research to investigate an alternative to chemotherapy
Plymouth University news: Researchers from Plymouth University have received a grant in the region of £600,000 from Cancer Research UK to investigate an alternative to chemotherapy for patients with mantle cell lymphoma
-
Cancer
Plymouth University Peninsula School of Medicine and Dentistry's internationally recognised translational research into the prevention, diagnosis and treatment of cancer